Educating Smokers About Lung Cancer Screening Using Tobacco Quitlines

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

• Ages 18 years and older
• All sexes
• Healthy volunteers accepted
• Adult, Older adult

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

About this study

Conditions

Lung Carcinoma

Being tested

Educational Intervention, Questionnaire Administration, Survey Administration

Medical subject headings

Lung Neoplasms

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

• Educational InterventionOther

  Also called Education for Intervention, Intervention by Education, Intervention through Education, Intervention, Educational

  Undergo training consisting of a 60-minute educational session

• Educational InterventionOther

  Also called Education for Intervention, Intervention by Education, Intervention through Education, Intervention, Educational

  Receive lung cancer screening educational materials

• Questionnaire AdministrationOther

  Complete questionnaire

• Survey AdministrationOther

  Ancillary studies

What is being measured

The primary outcome is the main question the study is designed to answer.

1. Content from communications (email, phone, monthly calls)

   Will be content analyzed using Atlas.ti qualitative software according to the adaptation framework from Stirman and colleagues. Will identify 1) who made the modification; 2) what was modified (i.e., content, context, training and evaluation); 3) for whom the modification was made (e.g., individual counselor); 4) context of the modification (e.g., format, setting, personnel, population); and 5) what was the nature of the modification (e.g., adding elements). Will also code for facilitators and barriers that are consistent with the constructs from CFIR. All textual data will be double coded and discussed by the researchers.

   Measured: Up to 4 years

2. Healthcare sector perspective

   As needed, will use a process-flow analysis to identify all resources utilized at each of the step of the program.

   Measured: Up to 4 years

3. Reach

   The analysis of the data from the logs and surveys will include examining the means, medians, standard deviations, and ranges overall and by state quitline for Reach

   Measured: During 6 month implementation period

4. Overall lung cancer screening rate

   Measured: Up to 6 months

5. Effectiveness (Caller Substudy)

   Will be successful if callers who participate in the evaluation answer at least 58 percent (7/12) of the Adapted lung cancer screening (LCS)-12 Knowledge Measure questions correctly and have a PrepDM score of at least 80 (standard deviation [SD] = 17.7), which were observed in the original project.

   Measured: Up to 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

1. First posted20 Oct 2020
2. Study start2 Jul 2020
3. Primary completion31 Oct 2026 (estimated)
4. Study completion31 Oct 2026 (estimated)

Resources

• Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
• Other trials for Lung CarcinomaStudies of the same condition, open and under way.
• More trials run by M.D. Anderson Cancer CenterThe sponsor's other registered studies.
• What the trial phases meanHow a treatment moves from first tests in people to approval.

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.